For age-old brands, it always seems more relevant to reaffirm an identity, establish legitimacy, build on history and continue to breathe new life into icons. At Cartier, this includes the launch of ...

CHICAGO, April 28, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced Tempus Loop ...

TD Cowen analyst Daniel Brennan maintained a Buy rating on Tempus AI, Inc. Class A (TEM – Research Report) today and set a price target of ...

Tempus AI, Inc. TEM is scheduled to report first-quarter fiscal 2025 results on May 6. In the last reported quarter, the company’s adjusted loss of 18 cents was wider than the Zacks Consensus ...

CHICAGO - Tempus AI, Inc. (NASDAQ: TEM), a leader in AI-driven precision medicine with a market capitalization of $9.15 billion, announced the launch of Tempus Loop, a new platform designed to ...

The new, proprietary target discovery platform integrates RWD, human biological modeling, and CRISPR screens to accelerate novel target identification Tempus AI, Inc. (NASDAQ: TEM), a technology ...

Tempus AI has a 52-week low of $22.89 and a 52-week high of $91.45. Insider Transactions at Tempus AI In related news, CEO Eric P. Lefkofsky sold 3,240,234 shares of Tempus AI stock in a ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced multi-year, strategic ...

The new, proprietary target discovery platform integrates RWD, human biological modeling, and CRISPR screens to accelerate novel target identification CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced that 18 abstracts, including ...